Literature DB >> 11259627

Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.

R Caballero1, E Delpón, C Valenzuela, M Longobardo, T González, J Tamargo.   

Abstract

In the present study, we analyzed the effects of two angiotensin II type 1 receptor antagonists, candesartan (0.1 microM) and eprosartan (1 microM), on hKv1.5, HERG, KvLQT1+minK, and Kv4.3 channels expressed on Ltk(-) or Chinese hamster ovary cells using the patch-clamp technique. Candesartan and eprosartan produced a voltage-dependent block of hKv1.5 channels decreasing the current at +60 mV by 20.9 +/- 2.3% and 14.3 +/- 1.5%, respectively. The blockade was frequency-dependent, suggesting an open-channel interaction. Eprosartan inhibited the tail amplitude of HERG currents elicited on repolarization after pulses to +60 mV from 239 +/- 78 to 179 +/- 72 pA. Candesartan shifted the activation curve of HERG channels in the hyperpolarizing direction, thus increasing the current amplitude elicited by depolarizations to potentials between -50 and 0 mV. Candesartan reduced the KvLQT1+minK currents elicited by 2-s pulses to +60 mV (38.7 +/- 6.3%). In contrast, eprosartan transiently increased (8.8 +/- 2.7%) and thereafter reduced the KvLQT1+minK current amplitude by 17.7 +/- 3.0%. Eprosartan, but not candesartan, blocked Kv4.3 channels in a voltage-dependent manner (22.2 +/- 3.5% at +50 mV) without modifying the voltage-dependence of Kv4.3 channel inactivation. Candesartan slightly prolonged the action potential duration recorded in guinea pig papillary muscles at all driving rates. Eprosartan prolonged the action potential duration in muscles driven at 0.1 to 1 Hz, but it shortened this parameter at faster rates (2--3 Hz). All these results demonstrated that candesartan and eprosartan exert direct effects on Kv1.5, HERG, KvLQT1+minK, and Kv4.3 currents involved in human cardiac repolarization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259627     DOI: 10.1124/mol.59.4.825

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylation.

Authors:  Tao Yang; Hideaki Kanki; Wei Zhang; Dan M Roden
Journal:  Br J Pharmacol       Date:  2009-06-12       Impact factor: 8.739

2.  Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.

Authors:  Ricardo Gómez; Lucía Núñez; Ricardo Caballero; Miguel Vaquero; Juan Tamargo; Eva Delpón
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.

Authors:  A Takahara; Y Nakamura; H Wagatsuma; S Aritomi; A Nakayama; Y Satoh; Y Akie; A Sugiyama
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

4.  Angiotensin II type 1 receptor mediates partially hyposmotic-induced increase of I (Ks) current in guinea pig atrium.

Authors:  Dimitar P Zankov; Futoshi Toyoda; Mariko Omatsu-Kanbe; Hiroshi Matsuura; Minoru Horie
Journal:  Pflugers Arch       Date:  2009-04-29       Impact factor: 3.657

5.  The role of the renin-angiotensin system blocking in the management of atrial fibrillation.

Authors:  Brett Cliff; Naveed Younis; Salam Hama; Handrean Soran
Journal:  J Drug Assess       Date:  2012-03-05

6.  The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China.

Authors:  Fazhong He; Jianquan Luo; Zhiying Luo; Lan Fan; Yijing He; Dingliang Zhu; Jinping Gao; Sheng Deng; Yan Wang; Yuesheng Qian; Honghao Zhou; Xiaoping Chen; Wei Zhang
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.